Dna X (SONM) Invested Capital (2018 - 2026)

Dna X (SONM) has 6 years of Invested Capital data on file, last reported at $37000.0 in Q3 2023.

• Quarterly Invested Capital fell 74.83% year-over-year to $37000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $37000.0 (down 92.26% YoY) and the FY2022 annual result came in at $147000.0, down 0.68% from the prior year.
• Invested Capital retreated to $37000.0 in Q3 2023, from $74000.0 in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $10.1 million in Q1 2020 to a low of $37000.0 in Q3 2023.
• A 5-year average of $1.2 million and a median of $148000.0 in 2021 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2020 — Invested Capital jumped 3484.04% — and 2021, when it plunged 98.25%.
• Tracing SONM's Invested Capital over 5 years: stood at $9.8 million in 2019, then sank by 98.2% to $177000.0 in 2020, then fell by 16.38% to $148000.0 in 2021, then retreated by 0.68% to $147000.0 in 2022, then slumped by 74.83% to $37000.0 in 2023.
• The last three Invested Capital figures came in at $37000.0 (Q3 2023), $74000.0 (Q2 2023), and $110000.0 (Q1 2023), per Business Quant data.